About this trial
This trial aims to evaluate the effectiveness of a multi-level, multi-component de-implementation strategy to reduce unnecessary preoperative testing. Sixteen Michigan Value Collaborative (MVC)/Michigan Surgical Quality Collaborative (MSQC) sites in Michigan will implement several tools that have been proven to reduce unnecessary testing at a single site, including clinician education, a decision aid, audit and feedback on performance, and a pay-for-performance incentive. The researchers believe that, through the use of these strategies, there will be a significant reduction in unnecessary preoperative testing during the intervention.
Eligibility criteria
Qualifiers
Over 30% of testing rates on at least one of the three index procedures (breast lumpectomy, laparoscopic cholecystectomy, and inguinal hernia repair)
Disqualifiers
none
Trial design
Treatments tested in this trial
- Active de-Implementation
Treatment groups
6
Treatment groupsSee each treatment group below.
Locations
1Sponsors and collaborators
University of Michigan
Lead sponsor
Agency for Healthcare Research and Quality (AHRQ)
Collaborator
Blue Cross Blue Shield of Michigan Foundation
Collaborator